EPISODE · Jan 17, 2020 · 15 MIN
Podcast 248: “Hotspotting” didn’t work in its home town — why?
from Clinical Conversations · host NEJM Group
The process of identifying super-users of healthcare and reducing the frequency of their hospitalizations — so-called “hotspotting” — was subjected to a randomized, controlled trial in Camden, NJ, the birthplace of the idea. It failed there. Those in the intervention group had a readmission rate within 6 months that was statistically identical to those getting usual care. True, the Camden patients had particularly complex social and medical problems, so that doesn’t mean that the program can’t work elsewhere. Listen to our chat with the report’s senior author, Prof. Joseph Doyle, and as well, listen to our interview with Dr. Jeffrey Brenner from 6 years ago — he’s the one who put “hotspotting” on the map. Despite the apparent failure of the trial, the Coalition still has a lot to offer. Results of the randomized trial in NEJM Interview with Dr. Jeffrey Brenner from 2013 Camden Coalition’s website Running time: 15 minutes The post Podcast 248: “Hotspotting” didn’t work in its home town — why? first appeared on Clinical Conversations.
Embed this episode
What this episode covers
The process of identifying super-users of healthcare and reducing the frequency of their hospitalizations — so-called “hotspotting” — was subjected to a randomized, controlled trial in Camden, NJ, the birthplace of the idea. It failed there. Those in the intervention group had a readmission rate within 6 months that was statistically identical to those getting usual care. […]
NOW PLAYING
Podcast 248: “Hotspotting” didn’t work in its home town — why?
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.